ES2154286T3 - Utilizacion de derivados de la beta-naftoquinona para la inhibicion de la agregacion plaquetaria. - Google Patents

Utilizacion de derivados de la beta-naftoquinona para la inhibicion de la agregacion plaquetaria.

Info

Publication number
ES2154286T3
ES2154286T3 ES94401461T ES94401461T ES2154286T3 ES 2154286 T3 ES2154286 T3 ES 2154286T3 ES 94401461 T ES94401461 T ES 94401461T ES 94401461 T ES94401461 T ES 94401461T ES 2154286 T3 ES2154286 T3 ES 2154286T3
Authority
ES
Spain
Prior art keywords
beta
derivatives
naftoquinone
inhibition
aggregation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94401461T
Other languages
English (en)
Inventor
Denis Blache
Christian Bloy
Bernard Hercelin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2154286T3 publication Critical patent/ES2154286T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UTILIZACION DE DERIVADOS DE LA BETA MULA (I): EN LA QUE R ES UN GRUPO EDICAMENTO QUE PERMITA INHIBIR LA AGREGACION PLAQUETARIA.
ES94401461T 1993-07-02 1994-06-28 Utilizacion de derivados de la beta-naftoquinona para la inhibicion de la agregacion plaquetaria. Expired - Lifetime ES2154286T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308112A FR2707495B1 (fr) 1993-07-02 1993-07-02 Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.

Publications (1)

Publication Number Publication Date
ES2154286T3 true ES2154286T3 (es) 2001-04-01

Family

ID=9448828

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94401461T Expired - Lifetime ES2154286T3 (es) 1993-07-02 1994-06-28 Utilizacion de derivados de la beta-naftoquinona para la inhibicion de la agregacion plaquetaria.

Country Status (13)

Country Link
US (1) US5523322A (es)
EP (1) EP0631777B1 (es)
JP (1) JP3993646B2 (es)
AT (1) ATE197669T1 (es)
CA (1) CA2127215C (es)
DE (1) DE69426317T2 (es)
DK (1) DK0631777T3 (es)
ES (1) ES2154286T3 (es)
FR (1) FR2707495B1 (es)
GR (1) GR3035058T3 (es)
HU (1) HU214058B (es)
PT (1) PT631777E (es)
RU (1) RU2122853C1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011151A3 (fr) * 1997-05-13 1999-05-04 Jose Remacle Utilisation d'une composition pharmaceutique dans le traitement et/ou la prevention de l'ischemie.
FR2796552A1 (fr) * 1999-07-21 2001-01-26 Centre Nat Rech Scient Nouvelle utilisation de derives de la beta-naphtoquinone et de leurs sels pour la fabrication de medicaments exercant un effet inhibiteur sur la liberation de glutamate dans le cerveau
RU2410104C1 (ru) * 2009-07-10 2011-01-27 Учреждение Российской академии медицинских наук Научный центр неврологии РАМН СПОСОБ СНИЖЕНИЯ АГРЕГАЦИОННОЙ АКТИВНОСТИ ТРОМБОЦИТОВ in vitro

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR924M (es) * 1959-09-26 1961-11-13
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents

Also Published As

Publication number Publication date
DK0631777T3 (da) 2001-03-05
PT631777E (pt) 2001-05-31
RU2122853C1 (ru) 1998-12-10
HU214058B (en) 1997-12-29
DE69426317T2 (de) 2001-05-03
ATE197669T1 (de) 2000-12-15
CA2127215C (fr) 2004-10-26
FR2707495B1 (fr) 1995-09-01
JP3993646B2 (ja) 2007-10-17
US5523322A (en) 1996-06-04
HU9401978D0 (en) 1994-09-28
JPH07145128A (ja) 1995-06-06
CA2127215A1 (fr) 1995-01-03
DE69426317D1 (de) 2000-12-28
FR2707495A1 (fr) 1995-01-20
HUT70508A (en) 1995-10-30
EP0631777B1 (fr) 2000-11-22
GR3035058T3 (en) 2001-03-30
EP0631777A1 (fr) 1995-01-04
RU94022757A (ru) 1996-09-27

Similar Documents

Publication Publication Date Title
AU573866B2 (en) Composition containing xanthine derivatives and o-acetylsalicylic acid
NO180166C (no) Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
DK0530505T3 (da) Hydantoinderivater
DE68903031D1 (de) N-acetyl-3-fluoroneuraminsaeure als antivirales arzneimittel.
EP0712844A4 (en) NEW CONDENSED CARBONIC ACID OR YOUR SALT AND YOUR MEDICAL USE
MX171542B (es) Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas
ES8102561A1 (es) Procedimiento de preparacion de los aril-1 arilsulfonil-4 a amino-propoxi-3 1h pirazoles
ES2154286T3 (es) Utilizacion de derivados de la beta-naftoquinona para la inhibicion de la agregacion plaquetaria.
FI903692A0 (fi) Salter av n5, n10-metylen-5,6,7,8- tetrahydrofolsyra.
ES2154285T3 (es) Utilizacion de derivados de la beta-naftoquinona para la aceleracion de la proliferacion de las celulas endoteliales y de la inhibicion de las no-sintasas.
ZA933455B (en) Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them
FR2355502A1 (fr) Application a titre de medicaments d&#39;un derive de la piperazine et de ses sels
DK114286A (da) Pyridylmethylnaphthylderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler
IE893578L (en) Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics
IE873212L (en) Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor
SE8004351L (sv) (3-alkylamino-2-hydroxipropoxi)-furan-2-karbonsyra-anilider och fysiologiskt fordragbara syraadditionssalter derav samt lekemedel med en halt av dessa foreningar
SE8601963D0 (sv) O-sulfated beta-lactam hydroxamic acids
ES508757A0 (es) &#34;procedimiento para la preparacion de acidos antranilicos sustituidos con radicales basicos&#34;
PT89236A (pt) Processo para a preparacao de compostos beta-lactamicos
FR2470111B1 (fr) Derives de la decaprenylamine, leurs sels acides d&#39;addition et composition pharmaceutique utilisant ces produits
FI941850A0 (fi) Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö
DE3786168D1 (de) Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien.
FR2627487B1 (fr) Nouveau derive de l&#39;acide valproique, procede de preparation de ce compose ainsi que medicament antiepileptique le contenant

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 631777

Country of ref document: ES